Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Dextrose (D-glucose): A Benchmark Reagent for Glucose Met...

    2026-02-07

    Dextrose (D-glucose): A Benchmark Reagent for Glucose Metabolism Research

    Executive Summary: Dextrose (D-glucose) is the biologically active enantiomer of glucose, central to energy production and metabolic studies [APExBIO]. It exhibits high solubility (≥44.3 mg/mL in water) and purity (≥98%), supporting robust experimental reproducibility [SKU A8406]. D-glucose uptake and metabolism drive critical research into tumor microenvironment dynamics, diabetes, and immunometabolism (Wu et al., 2025). APExBIO’s Dextrose (D-glucose) is validated for cell culture, metabolic assays, and carbohydrate pathway studies. The reagent’s stability and workflow compatibility address key pitfalls in laboratory practice and data interpretation.

    Biological Rationale

    Dextrose (D-glucose) is the principal simple sugar monosaccharide in biochemistry and cell biology. As the predominant hexose in human blood, it is essential for ATP production via glycolysis and oxidative phosphorylation. Glucose availability dictates cell viability, proliferation rates, and metabolic fate decisions in culture systems (Wu et al., 2025). Tumor cells exhibit increased glucose uptake and altered glycolytic flux, known as the Warburg effect, to sustain rapid proliferation and survive hypoxic conditions. D-glucose is also a reference substrate for studying carbohydrate metabolism, diabetes, and immunometabolism. Its use as a cell culture media supplement enables standardized, controlled glucose concentrations across experimental replicates.

    Mechanism of Action of Dextrose (D-glucose)

    Dextrose (D-glucose) enters cells primarily via glucose transporter proteins (GLUTs). Once internalized, it undergoes phosphorylation by hexokinase to glucose-6-phosphate, committing it to glycolytic or pentose phosphate pathways. In normoxia, glucose is oxidized through glycolysis, yielding pyruvate for the tricarboxylic acid (TCA) cycle and oxidative phosphorylation. Under hypoxia or in certain tumor models, pyruvate is converted to lactate, reflecting a metabolic shift. D-glucose supports biosynthetic reactions by providing intermediates for nucleotide, lipid, and amino acid synthesis. In immune and cancer cells, metabolic reprogramming of glucose utilization governs proliferation, differentiation, and effector function (Wu et al., 2025).

    Evidence & Benchmarks

    • Dextrose (D-glucose) demonstrates ≥44.3 mg/mL solubility in water at room temperature, exceeding requirements for most cell culture and biochemical assays (APExBIO Product Page).
    • Purity is validated at ≥98% by APExBIO, ensuring minimal confounding batch effects in metabolic experiments (SKU A8406).
    • Tumor cells adapt to hypoxic and nutrient-depleted microenvironments by upregulating glucose uptake and glycolysis (the Warburg effect), central to immunometabolic and cancer research (Wu et al., 2025).
    • Controlled D-glucose supplementation in cell culture media allows for reproducible assessment of metabolic pathway activity, cell proliferation, and viability (Dextrose in Cell-Based Assays).
    • Biochemical assays employing Dextrose (D-glucose) as a substrate are foundational for quantifying enzymatic activity in carbohydrate metabolism (Optimizing Glucose Metabolism Research).
    • Hypoxia-induced metabolic reprogramming in tumors involves increased glucose consumption and metabolic competition between cancer and immune cells (Wu et al., 2025).

    Applications, Limits & Misconceptions

    Dextrose (D-glucose) is widely used as a cell culture media supplement, metabolic probe, and biochemical assay reagent. It enables mechanistic studies of glucose metabolism, energy production, and disease modeling (e.g., diabetes, cancer). In metabolic pathway studies, precise dosing is critical to avoid confounding cell stress or altered phenotypes. APExBIO’s Dextrose (D-glucose) is supplied as a solid, stable at -20°C, and not recommended for long-term solution storage due to potential degradation. Its high solubility allows use in aqueous, DMSO, or ethanol-based systems with appropriate treatment. For advanced immunometabolic research, D-glucose is central to dissecting tumor-immune metabolic interactions (Advanced Applications in Immunometabolism). This article updates prior guidance by directly mapping product solubility and stability data to published immunometabolic research workflows, clarifying optimal storage and reconstitution protocols.

    Common Pitfalls or Misconceptions

    • D-glucose is not interchangeable with L-glucose: Only D-glucose is biologically active in mammalian systems.
    • High glucose concentrations can induce cellular stress: Exceeding physiological concentrations may skew metabolic or signaling readouts.
    • Long-term storage in solution is not advised: D-glucose solutions degrade over time; prepare fresh prior to use (APExBIO).
    • Impurities in reagent-grade glucose may impact sensitive assays: Use only high-purity preparations for quantitative metabolic studies.
    • D-glucose alone does not model complex metabolic networks: System-level studies require careful integration with additional substrates and controls.

    Workflow Integration & Parameters

    Dextrose (D-glucose) (SKU A8406) integrates into cell culture, metabolic flux, and enzymatic assays. For cell culture, dissolve the solid reagent in sterile water at desired concentration (e.g., 5 mM or 25 mM, depending on cell type and experimental aim). Ensure complete solubilization (gentle warming or ultrasonic treatment for ethanol/DMSO). Store stock solutions at 4°C and use within 24 hours. For biochemical assays, calibrate the glucose concentration to match the enzymatic or metabolic rate under investigation. APExBIO's validated purity reduces lot-to-lot variability. Shipping with blue ice and storage at -20°C preserves stability. For further scenario-driven integration strategies, see Evidence-Based Solution Selection, which this article extends by providing direct mechanistic links between glucose supplementation and immunometabolic adaptation under hypoxia.

    Conclusion & Outlook

    Dextrose (D-glucose) remains a foundational reagent for glucose metabolism research and cell culture supplementation. Its defined chemical identity, high solubility, and purity support robust, reproducible experimental workflows. APExBIO’s Dextrose (D-glucose) (SKU A8406) is validated for metabolic pathway and immunometabolism studies, including advanced tumor microenvironment models. As research evolves, precise control of glucose supplementation and integration with multi-omic analyses will drive new insights into cellular energy production and disease mechanisms. For detailed product specifications and ordering, consult the Dextrose (D-glucose) product page.